Condition 1: Covid-19. Condition 2: Covid-19. COVID19, virus identified COVID19, virus not identified
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, in addition to the standard treatment, medicinal herbal products will be prescribed.The drug will be given in syrup form. The syrup will
Sponsors
Ardabil University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients over 18 years old Hospitalized patients withprobable or confirmed COVID-19 based on radiologicalfindings or positive PCR test according to the instructions22of the Ministry of Health Clinically classified as moderateand severe, no need for intubation Written and informedsatisfaction of patients
Exclusion criteria
Exclusion criteria: Liver, kidney and heart failure History of allergies to medicinal herbs Immunodeficiency Uncontrolled hypertension Uncontrolled diabetes Alcohol or drug addiction Patients with transplanted organs Cor Pulmonel Patients Takinganticoagulants, antiarrhythmics, antihypertensives, corticosteroids and immunosuppressants Pregnancy Breast feeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oxygen saturation. Timepoint: Clinical examination and Pulse Oximetry before starting intervention and regularly during hospitalized. Method of measurement: Pulse Oximeter.;Respiratory Rate. Timepoint: Clinical examination before starting intervention and regularly during hospitalized. Method of measurement: Respiratory Count. | — |
Secondary
| Measure | Time frame |
|---|---|
| C-reactive protein. Timepoint: Intravenous blood testing before starting intervention and during hospitalized. Method of measurement: Venous blood test.;Lymphocytes. Timepoint: Intravenous blood testing before starting intervention and during hospitalized. Method of measurement: Venous blood test.;White Cell blood count. Timepoint: Intravenous blood testing before starting intervention and during hospitalized. Method of measurement: Venous blood test.;Liver enzymes. Timepoint: Intravenous blood testing before starting intervention and during hospitalized. Method of measurement: Venous blood test.;Cough. Timepoint: Clinical examination before starting intervention and regularly during treatment. Method of measurement: Patient follow up.;Fever. Timepoint: Clinical examination before starting intervention and regularly during treatment. Method of measurement: Thermometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRamin Nasimi Doost Azgomi
Ardabil University of Medical Sciences
Outcome results
None listed